+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application

  • ID: 5023773
  • Report
  • April 2020
  • Region: Global
  • 177 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Acrotech Biopharma, Inc.
  • Astellas Pharma, Inc.
  • Celsion Inc.
  • Gilead Sciences, Inc.
  • Ipsen Pharma
  • Luye Pharma Group
  • MORE
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.

The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery solutions, increasing R& D expenditures in pharmaceutical companies. However, high cost involved in the development of drug delivery systems is expected to obstruct the growth of the market to a certain extent during the forecast period.

With the improvements in medical science and certain oral drug delivery technologies, the noninvasive mode of drug delivery system is now ready to compete with traditional methods of injectable and painful routes of drug delivery. The non-invasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by noninvasive routes due to decreased pain involved in drug delivery. Therefore, these techniques are considered to be a preferred mode of drug delivery. The traditional drug delivery techniques, such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations owing to negative aspects associated with the traditional drug delivery techniques. The noninvasive method of drug delivery system has simplified dosing schedules and is accustomed to the patients. Moreover, noninvasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing costs are also comparatively less for noninvasive dosage forms than injections. Thus, due to advantages offered by noninvasive drug delivery devices, the liposome drug delivery market is expected to witness growth during the forecast period.

The global liposome drug delivery market is segmented into product, technology, application, and geography. The liposome drug delivery market, by product, is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest share by product owing to the high efficacy of the drug exhibited in the treatment of cancer. Moreover, the liposomal doxorubicin is beneficial over its traditional counterparts in terms of toxicity and targeted drug delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi's sarcoma and multiple myeloma. Based on technology, the liposome drug delivery market is segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. Based on application, the liposome drug delivery market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy.

Some of the crucial secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, National Institute of Cancer Prevention and Research (NICPR), Ministry of Food and Drug Safety (MFDS), International Diabetes Federation (IDF), and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liposome drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acrotech Biopharma, Inc.
  • Astellas Pharma, Inc.
  • Celsion Inc.
  • Gilead Sciences, Inc.
  • Ipsen Pharma
  • Luye Pharma Group
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Liposome Drug Delivery Market - By Product
1.3.2 Global Liposome Drug Delivery Market - By Technology
1.3.3 Global Liposome Drug Delivery Market - By Application
1.3.4 Global Liposome Drug Delivery Market - By Geography

2. Liposome Drug Delivery Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Liposome Drug Delivery - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe- PEST Analysis
4.2.2 Asia Pacific- PEST Analysis
4.2.3 Middle East & Africa
4.2.4 South and Central America
4.3 Expert Opinion

5. Global Liposome Drug Delivery Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis

6. Liposome Drug Delivery Market - Global Analysis
6.1 Global Liposome Drug Delivery Market Revenue Forecast And Analysis
6.2 Global Liposome Drug Delivery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Liposome Drug Delivery Market Analysis - By Product
7.1 Overview
7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
7.3 Liposomal Doxorubicin
7.3.1 Overview
7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Liposomal Paclitaxel
7.4.1 Overview
7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Liposomal Amphotericin B
7.5.1 Overview
7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Liposome Drug Delivery Market - By Technology
8.1 Overview
8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Liposome Drug Delivery Market - By Application
9.1 Overview
9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Liposome Drug Delivery Market - Geographic Analysis
10.1 North America: Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 North America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Liposome Drug Delivery Market
10.2.1 Overview
10.2.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.8.3 United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.8.4 United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Liposome Drug Delivery Market
10.3.1 Overview
10.3.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.3.7 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Liposome Drug Delivery Market
10.4.1 Overview
10.4.2 Middle East & Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Liposome Drug Delivery Market
10.5.1 Overview
10.5.2 South and Central America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic On Global Liposome Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Liposome Drug Delivery Market -Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview

13. Liposome Drug Delivery Market -Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Novartis AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Luye Pharma Group
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Services, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ipsen Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gilead Sciences, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Celsion, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Astellas Pharma Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Acrotech Biopharma LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pacira BioSciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Luye Pharma Group
  • Ipsen Pharma
  • Celsion Inc.
  • Gilead Sciences, Inc.
  • Astellas Pharma, Inc.
  • Johnson & Johnson Services, Inc.
  • Acrotech Biopharma, Inc.
  • Pacira Biosciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll